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a  b  s  t  r  a  c  t
Recent  public  health  threats  have  propelled  major  innovations  on infectious  disease  monitoring,
culminating  in  the  development  of  innovative  syndromic  surveillance  methods.  Inﬂuenzanet  is an
internet-based  system  that monitors  inﬂuenza-like  illness  (ILI)  in  cohorts  of  self-reporting  volunteers
in  European  countries  since  2003.  We  investigate  and  conﬁrm  coherence  through  the  ﬁrst ten  years  in
comparison  with  ILI  data  from  the  European  Inﬂuenza  Surveillance  Network  and  demonstrate  country-eywords:
yndromic surveillance
nﬂuenza-like illness
ime series
isk factors
accine effectiveness
speciﬁc  behaviour  of  participants  with  ILI  regarding  medical  care  seeking.  Using  regression  analysis,  we
determine  that  chronic  diseases,  being  a child,  living  with  children,  being  female,  smoking  and  pets  at
home,  are  all  independent  predictors  of ILI  risk,  whereas  practicing  sports  and  walking  or bicycling  for
locomotion  are  associated  with  a small  risk  reduction.  No  effect  for using  public  transportation  or  living
alone  was  found.  Furthermore,  we  determine  the  vaccine  effectiveness  for ILI for  each season.
© 2015  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license. Introduction
Recent concerns with emerging infectious diseases have
xposed deﬁciencies in disease surveillance systems and impelled
adical rethinking on how to monitor population health and
etect anomalies in real time (Butler, 2006). In this context, new
pproaches in syndromic surveillance – the collection and inter-
retation of data for public health before laboratory or clinical
onﬁrmation is available (Lazarus et al., 2001; Mandl et al., 2004)
 have emerged. Several systems are in evaluation, showing a
arge diversity of data sources and methodologies employed, such
s telephone-based health information services (Cooper et al.,
008), automated medical records (Lazarus et al., 2001; van den
ijngaard et al., 2008), pharmacy sales and absenteeism (Chretien
t al., 2008), queries to online search engines (Ginsberg et al.,
009), and telephone-based self-reporting in cohorts of randomly
elected participants (Merk et al., 2013; Rehn et al., 2014). Syn-
romic surveillance is complementary to traditional public health
∗ Corresponding author at: Instituto de Matemática e Estatística da Universidade
e São Paulo, Rua do Matão, 1010, CEP 05508-090 São Paulo, SP, Brazil.
E-mail address: vanNoort@gmail.com (S.P. van Noort).
ttp://dx.doi.org/10.1016/j.epidem.2015.05.001
755-4365/© 2015 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
surveillance in disease reporting (Henning, 2004; Lipsitch et al.,
2009).
Inﬂuenzanet is a monitoring system for inﬂuenza-like illness
(ILI) in voluntary cohorts of internet users. It was  initially con-
ceived to make scientiﬁc information accessible to a broad public
and to kindle students’ enthusiasm for science, and was  launched
in the Netherlands and Belgium (www.degrotegriepmeting.nl) in
2003 and in Portugal (www.gripenet.pt) in 2005. The system was
consecutively implemented in Italy (www.inﬂuweb.it) in 2008,
United Kingdom (www.ﬂusurvey.org.uk) in 2009, Sweden (www.
halsorapport.se) in 2011, France (www.grippenet.fr) and Spain
(www.gripenet.es) in 2012, and Denmark (www.inﬂumeter.dk)
and Ireland (www.ﬂusurvey.ie) in 2013. Similar systems have been
implemented outside Europe, most notably in Australia (www.
ﬂutracking.net) in 2007, Mexico (reporta.c3.org.mx) in 2009, and
the United States (www.ﬂunearyou.com) in 2011.
Based on single-season analysis, previous studies established
good correlations between ILI incidences as determined by
Inﬂuenzanet and by the clinical surveillance by sentinel General
Practitioners (GPs) as coordinated by the European Centre for
Disease Prevention and Control (ECDC) (Friesema et al., 2009;
Marquet et al., 2006; van Noort et al., 2007; Paolotti et al., 2014;
Vandendijck et al., 2013). The absolute ILI incidence as reported by
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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nﬂuenzanet is, however, much more consistent across countries
ccording to Inﬂuenzanet than reported by the ECDC, due to coun-
ry speciﬁc medical care seeking rates and disparities in ILI case
eﬁnitions used by GPs in different countries (van Noort et al.,
007). This uniformity in rates reported across European countries
acilitates the geographical analysis and modelling of epidemics
van Noort et al., 2012). In the United Kingdom (Eames et al., 2012a)
nd France (Debin et al., 2014), the vaccine effectiveness for ILI has
een determined for a single season. By integrating serological data
ources, ILI rates reported by Inﬂuenzanet have been converted to
stimates of inﬂuenza attack rates (Patterson-Lomba et al., 2014).
Here we aim to further establish the Inﬂuenzanet system as a
alid sentinel for ILI surveillance, by conﬁrming that both the tim-
ng and relative intensities of epidemics are consistent with those
eported by ECDC, and the identiﬁed risk factors for ILI are consis-
ent with those in the published literature. The analysis is based
n data collected over the ﬁrst 10 seasons (2003–2013) from the
ountries in which Inﬂuenzanet was implemented for at least 5
easons: the Netherlands, Belgium, Portugal, and Italy. Time series
nalyses are applied to compare ILI incidences from Inﬂuenzanet
nd ECDC, whereas regression analysis is used to determine indi-
idual risk factors based on personal characteristics and vaccination
tatus. Furthermore, based on the health care seeking behaviour as
eported to Inﬂuenzanet, differences in ILI incidence by Inﬂuen-
anet and ECDC are explained.
. Method
.1. Data collection
Inﬂuenzanet participants are recruited from the general popu-
ation by completing an intake questionnaire on one of the national
ebsites, containing various demographic and life style questions.
uring the inﬂuenza season, participants receive a weekly newslet-
er by e-mail in which they are directed to an online questionnaire
bout a number of symptoms that they might have experienced
ince their last report. The Ethics Committee of Instituto Gulbenkian
e Ciência approved the study.
.2. Participants
An active population of participants is essential for the consis-
ency of the system. An important cornerstone for success is the
eedback of information to keep the participants involved and moti-
ated. Although the speciﬁc recruitment strategies vary between
ountries (Bajardi et al., 2014), they tend to be based on mass
ommunication. The websites contain a wealth of information on
nﬂuenza, ILI and common cold, while the educational and scientiﬁc
ims of the project are explained in direct mailings to schools, in
epeated interviews on television and radio, and in newspapers.
chools are provided with educational material on inﬂuenza to
romote incorporation of ideas of disease surveillance in science
lasses. At the beginning of each season, all participants from pre-
ious seasons are sent an email inviting them to participate again
y completing an intake questionnaire for the new season. Based on
 unique user id, participants can be tracked over multiple seasons.
.3. Bias
Public health statistics such as asthma, diabetes and inﬂuenza
accination rates in the Inﬂuenzanet participants have been shown
o be similar for the Dutch (Marquet et al., 2006) and Belgian
Vandendijck et al., 2013) populations. Although younger and
lder age groups are underrepresented in Inﬂuenzanet (Cantarelli
t al., 2014), these differences did not seem to have an impact
n the observed ILI trends (van Noort et al., 2007). To minimizeics 13 (2015) 28–36 29
the selection bias in recruiting participants who already have ILI,
any symptoms that started before or on the registration date are
excluded from the analysis. Only participants who  participate at
least 3 times during a season are included in the analyses.
2.4. ILI incidence
ILI is deﬁned as the acute onset (within a few hours) of fever
(a measured temperature of at least 38 ◦C), together with mus-
cle pain or headache, and cough or sore throat. The day of fever
onset determines the day of ILI onset. Participants are considered
active between registration date and the date of their last com-
pleted symptoms’ questionnaire. ILI incidence is determined by
dividing the number of ILI onsets per week by the number of active
participants. If participants ﬁt the ILI case deﬁnition in consecutive
questionnaires, this is considered as a single ILI episode.
2.5. European Inﬂuenza Surveillance Network
The clinical surveillance of inﬂuenza in the European Inﬂuenza
Surveillance Network (EISN, formally EISS), coordinated by the
ECDC, is generally based on reports made by sentinel GPs. The ILI
incidence for each country is determined by the number of patients
who visit their (sentinel) GP and ﬁt the (country-speciﬁc) ILI case
deﬁnition (Aguilera et al., 2003), divided by the total number of
people assigned to the participating GPs.
2.6. Crosscorrelation
For each country, the crosscorrelation between ILI incidence
rates as reported by ECDC and Inﬂuenzanet is determined. Since
both time series are autocorrelated and share a common seasonal
trend, this direct crosscorrelation could give a misleading indica-
tion of their relationship (Bloom et al., 2007). Therefore, both time
series are also prewhitened by ﬁtting seasonal ARIMA models using
the Box–Jenkins approach (Allard, 1998), where the model with
the lowest Akaike information criterion is selected (Hyndman and
Athanasopoulos, 2014). The detrended time series are obtained by
ﬁltering each time series by the selected model, and for each coun-
try the crosscorrelation between the detrended time series from
Inﬂuenzanet and ECDC is determined.
Since the ILI incidence from Inﬂuenzanet is based on the
reported day of onset and the ILI incidence from ECDC is deter-
mined by the week a patient visited their GP, it would be expected
that the reported ILI incidence from Inﬂuenzanet precedes the ILI
incidence as determined by ECDC. Since in Inﬂuenzanet not only
the week of onset but the actual day is recorded, the weekly ILI
incidence from Inﬂuenzanet can be shifted by single days, where a
shift of zero days indicates that the ILI incidence from both systems
is compared for the period Monday-Sunday.
2.7. Medical care seeking behaviour
Each participant who  reports (ILI) symptoms, is asked some
follow-up questions, such as whether the participant visited a
medical doctor. This allows the determination of the percentage
of participants with ILI who seek medical care. Since participants
could seek medical care after they have reported their symptoms
to Inﬂuenzanet, a reported visit within 15 days after a reported
ILI onset is still considered. Since season 2011–2012, Inﬂuenzanet
participants who  reported to have visited a medical doctor are also
asked how many days elapsed between the onset of symptoms and
the visit.
3 Epidemics 13 (2015) 28–36
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Table 1
Crosscorrelation between Inﬂuenzanet and ECDC for daily lags based on the
detrended time series (2003–2013). Values in bold indicate the crosscorrelation at
a  lag equal to the median number of days between ILI onset and visit to a medical
doctor.
Lag (days) Netherlands Belgium Portugal Italy
−7 0.33 0.34 0.27 −0.06
−6  0.40 0.42 0.23 −0.02
−5  0.40 0.45 0.32 0.09
−4  0.47 0.52 0.32 0.19
−3 0.46 0.50 0.35 0.24
−2 0.39  0.57 0.35 0.22
−1  0.32 0.57 0.42 0.24
0  0.38 0.53 0.38 0.29
1  0.34 0.46 0.22 0.24
2  0.35 0.44 0.22 0.20
3  0.34 0.37 0.24 0.18
4 0.31 0.40 0.13 0.160 S.P. van Noort et al. / 
.8. Risk factor analysis
We  apply a logistic regression model to explore the associa-
ion between several individual covariates and the occurrence of at
east one ILI episode during a season. These covariates are selected
eforehand, consisting mostly of characteristics which have been
dentiﬁed in other studies regarding inﬂuenza risk, and some extra
haracteristics which are not normally analyzed. Most covariates
re considered equal across all seasons: age group (<15, 15–49,
0–64, 65+), household situation (alone, with children or with only
dults), gender, chronic disease (asthma, diabetes, heart disease,
nd/or immuno-compromised), smoking, sports (at least 1 h per
eek), pets at home (dogs, cats, and/or birds), and primary mode of
aily locomotion (bicycle/foot, car, or public transport). The covari-
te “risk group (others)” includes those participants who report to
elong to a risk group, but are younger than 65 years (60 in the
etherlands since 2008) and did not report any of the chronic dis-
ases. The effect of vaccination is considered as a season-dependent
ovariate. For the season 2009–2010, the vaccine status is based on
he pandemic vaccine. Country of residence and season (indirectly)
re two extra covariates.
Only ILI onsets during the weeks when inﬂuenza strains were
irculating in the population are considered. These periods are
eﬁned for each season and country as the weeks when the num-
er of inﬂuenza-conﬁrmed samples as reported by ECDC was  at
east 15% of the maximum for that season (moving average over 3
eeks) (Supplementary Figure S13). All participants are considered
ndependent between two different seasons, and participants who
ere not active for the complete inﬂuenza period are excluded.
ince Inﬂuenzanet is a cohort study in which healthy individuals
without ILI) are recruited and the possible onset of ILI is moni-
ored over a ﬁxed period of time, Inﬂuenzanet can determine the
isk ratios for all the covariates. For each covariate a univariate risk
atio is determined. Adjusted risk ratios are determined by a mul-
ivariate log-binomial regression model including all global and
eason-dependent covariates analyzed by the general linear model
n R software (R Development Core Team, 2014). The variance inﬂa-
ionary factor (VIF) for each covariate is determined to check for
ollinearity in the multivariate regression model.
. Results
.1. ILI incidence
The ILI incidence as determined by Inﬂuenzanet correlates
ell over multiple seasons with the ILI incidence as reported by
CDC (Fig. 1). However, Inﬂuenzanet measures ILI incidence in all
ountries on the same scale, while the incidences reported by ECDC
re in general lower and vary in scale between countries.
The crosscorrelation between the raw ILI incidences from
nﬂuenzanet and ECDC is signiﬁcant (Fig. 2A, C, E, and G). The ILI
ncidences show a high level of autocorrelation and some degree
f seasonality (Supplementary Figures S5–S12A). We  ﬁtted to each
ime series a seasonal ARIMA model (Supplementary Table S1), and
ltered the time series by each model to obtain a detrended time
eries (Supplementary Figures S1–S4). The detrended time series
re no longer autocorrelated (Supplementary Figures S5–S12B), as
onﬁrmed by the Ljung–Box test (Supplementary Table S1). The
etrended time series of Inﬂuenzanet and ECDC also show a signif-
cant level of crosscorrelation at a lag of zero weeks (Fig. 2B, D, F,
nd H), for the Netherlands (0.38), Belgium (0.53), and Italy (0.29)..2. Medical care seeking behaviour
The percentage of participants with ILI who seeked medical care
aries greatly by country (Fig. 3). Similar differences are observed5  0.35 0.32 0.17 0.17
6  0.34 0.24 0.06 0.16
7  0.19 0.24 0.15 0.18
in the number of days between the onset of symptoms and visiting
the doctor (Fig. 4). The observed patterns do not change if only
working adult participants are considered in the analysis.
The crosscorrelation between the detrended time series from
Inﬂuenzanet and ECDC is maximum when a shift of 4 days is applied
in the Netherlands, 1–2 days in Belgium, 1 day in Portugal, and no
shift in Italy (Table 1). This corresponds well with the median delay
between ILI onset and seeking medical care as reported during the
seasons 2011–2013: 4 days in the Netherlands, 2 days in Belgium,
1 day in Portugal, and 1 day in Italy.
3.3. Participation
The Netherlands has most participants (on average 19,491 per
season, of which 16,481 completed at least 3 symptoms’ question-
naires), followed by Belgium (6001; 5072), Portugal (2871; 1894),
and Italy (1882; 1219) (Fig. 5). This corresponds to 0.1% of the pop-
ulation in the Netherlands and Belgium (Flanders, since basically
all participants are from Flanders), 0.02% in Portugal, and 0.003%
in Italy. Of all participants who completed at least 3 symptoms
questionnaires during a season, in the Netherlands 76 ± 8% partici-
pated again in the following season, 74 ± 12% in Belgium, 69 ± 12%
in Portugal, and 70 ± 4% in Italy.
3.4. Risk factors
The univariate risk ratios are listed in the Supplementary
material (Table S2), whereas the adjusted risk ratios from the
multivariate regression are listed in Table 2. The variance inﬂa-
tionary factor (VIF) for the covariates varies between 1.0 and 2.7
(Supplementary Table S2), reassuring that model speciﬁcation is
not compromised by undesirable collinearities (O’Brien, 2007).
McFadden’s pseudo R-squared for the ﬁnal model ﬁt (R2 = 0.035)
is relatively low, indicating that only a small part of the variation
in ILI infections is explained by the presented covariates. The pri-
mary risk factor for acquiring an infection is having contact with an
infectious person and this is absent from these analyses.
According to the adjusted risk ratios, having a chronic disease
(asthma, diabetes, heart disease and/or immune-compromising
condition), living with children, being female, belonging to a
younger age group, pets at home (cats and/or dogs), and being a
smoker, were all independent predictors of the risk of having at
least one ILI episode during a ﬂu season (Table 2). A small risk
reduction was  observed in participants who primarily use bicycle
or foot for locomotion (compared to a car) and participants who
practice more than 1 h of sports per week. No signiﬁcant effect was
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Iig. 1. ILI incidence for Inﬂuenzanet and ECDC for (A) the Netherlands, (B) Belgium
LI  onsets per 100,000 participant-weeks. The vertical axes for the ILI incidence are 
bserved for participants who live with other adults (compared to
iving alone), participants who have birds at home, and participants
ho use public transportation (compared to using a car).
The vaccine effectiveness for inﬂuenza-like illness varies from
eason to season. A signiﬁcant reduction in ILI due to vaccination
as observed in the seasons 2007–2008, 2008–2009, 2010–2011,
nd 2012–2013, while no signiﬁcant effect was  observed in other
easons. The vaccine effectiveness for season 2009–2010 is possibly
nderestimated, since the vaccine only became available when the
LI activity was already epidemic.
. Discussion
Based on single-season analysis, previous studies established
xcellent correlations between ILI incidences as determined by
nﬂuenzanet and by ECDC (Friesema et al., 2009; Marquet et al.,
006; van Noort et al., 2007). A question remained on whether this
onsistency would persist for multiple-season data streams. We
howed that during 10 seasons in the Netherlands and Belgium
2003–2013), 8 seasons in Portugal (2005–2013), and 5 seasons in
taly (2008–2013), the ILI trends from Inﬂuenzanet and ECDC areortugal and (D) Italy. The ILI incidence by Inﬂuenzanet is deﬁned as the number of
 based on a linear regression between the ILI incidences of Inﬂuenzanet and ECDC.
consistent in both timing and relative magnitude, with a signiﬁcant
crosscorrelation between both time series as lags of zero weeks. The
signal from Inﬂuenzanet precedes ECDC by a few days, correspond-
ing approximately to the median number of days between ILI onset
and seeking medical care. However, this does not necessary indicate
that in real-time monitoring Inﬂuenzanet would detect ILI trends
earlier, since this depends on when the data becomes available and
the statistical uncertainties in the data (van Noort, 2014).
Although both time series are correlated over the full 10-year
period, there are localized discrepancies between the data streams,
which could be attributed to the different methodology and com-
position of the cohorts in both systems. As an example, young
children are largely underrepresented in Inﬂuenzanet (van Noort
et al., 2007), whereas young children visit relatively more often a
medical doctor. This could explain why for the season 2007–2008 in
Portugal, dominated by the inﬂuenza B strain affecting mostly chil-
dren, a small epidemic was  reported by ECDC which went mostly
undetected by Inﬂuenzanet. Another local discrepancy is the rel-
atively high ILI incidence as reported by ECDC in the Netherlands
during the months preceding the 2009 ILI pandemic, which might
be attributed to an increase in awareness by medical doctors and
32 S.P. van Noort et al. / Epidemics 13 (2015) 28–36
F  eithe
a –2013
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p
F
mig. 2. Cross-correlation between the ILI incidences of Inﬂuenzanet and ECDC using
nd  B) Netherlands, (C and D) Belgium, (E and F) Portugal and (G and H) Italy (2003
atients due to a global concern about the new H1N1 inﬂuenza
train (Keramarou et al., 2011).The presence of multiple independent sources encourages the
evelopment of integrative methods that explore the speciﬁc
trengths of each system (Reis et al., 2007). Having multiple inde-
endent systems could uncover aspects of inﬂuenza transmission
ig. 3. Inﬂuenzanet participants with ILI who visited a medical doctor speciﬁed by coun
easured temperature of at least 38 ◦C), together with muscle pain or headache, and cour the raw ILI incidences (left panel) or the detrended time series (right panel) in (A
).
that would go unnoticed if only one data stream was available.
Another cross-country data source for ILI incidences is Google Flu
Trends (Ginsberg et al., 2009), which determines ILI incidence based
on the frequency of ILI-related search terms. However, Google Flu
Trends is not a strictly independent data source, since their algo-
rithms rely on the ECDC data streams for calibration.
try (2011–2013). ILI is deﬁned as the acute onset (within a few hours) of fever (a
gh or sore throat.
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fig. 4. Time lag between ILI onset and visit to medical doctor in (A) Sweden, (B) U
H)  Italy (2011–2013). ILI is deﬁned as the acute onset (within a few hours) of fever
ough  or sore throat.
Patterns in medical care seeking behaviour suggest cultural
ifference between northern and southern Europe. In southern
urope (France, Italy, Portugal, and Spain) participants generally
isit a medical doctor within 1–2 days after the onset of symp-
oms, whereas in northern Europe (Sweden, United Kingdom, and
he Netherlands) participants seek medical care generally only 5–7
ays after the onset of symptoms. Belgium (Flanders) seems an
xception to the suggested pattern, most likely because accord-
ng to Belgian law, an employer can require from their employee
 medical statement within 24 h to justify work absenteeism. A
imilar pattern is observed in the percentage of participants with
LI who seek medical care, which is lower in the northern Europe
except Belgium) than in southern Europe. The two patterns could
e associated by considering that in countries where participants
ait longer before seeking medical care, many participants would
o longer feel sufﬁciently ill to warrant a visit to a medical doctor.
This variation in medical care seeking rates across countries is
ne of the reasons why ILI incidences reported by ECDC cannot
e compared directly (van Noort et al., 2007). Variations in med-
cal care seeking could also affect the determined ILI incidence
y ECDC within a country, if certain subgroups of the population
isit a doctor at different rates. Inﬂuenzanet does not only serve
s an independent source for ILI activity, but could also be used to
alibrate ILI data as collected by GP sentinel systems (van Noort,
014).
A crucial element in the success of Inﬂuenzanet, is having a sufﬁ-
iently large cohort of participants. In the Netherlands (on average
6,481 active participants), Belgium (5072), Portugal (1894), and
taly (1219) the Inﬂuenzanet cohort was large enough to detect
imilar ILI epidemics as ECDC in all seasons, with the exception
f season 2007–2008 in Portugal. Larger cohorts would lead to
ower statistical noise such that epidemics could be detected earlier
nd even small ILI epidemics could be distinguished from base-
ine ILI activity. Furthermore, in larger cohorts, different subgroups,
or example based on age or vaccine status, could be monitoredKingdom, (C) the Netherlands, (D) Belgium, (E) France, (F) Spain, (G) Portugal and
asured temperature of at least 38 ◦C), together with muscle pain or headache, and
separately. Of all active participants during a certain season,
73 ± 11% participated again in the following season. Although this
shows impressive loyalty of participants, each season an effort
should be made to recruit new participants to at least replace those
who have left.
Risk factors estimated from the Inﬂuenzanet cohort are con-
sistent with the inﬂuenza literature. Higher risk of ILI in children
and in those living with children was  observed, in consistency with
observational studies (Cauchemez et al., 2009; Monto and Ross,
1977; Monto, 2004; Viboud et al., 2004). The increased ILI risk in
women compared to men, which may  be due to more intensive
contact between women  and children, has also been previously rec-
ognized (Monto and Ross, 1977). We  found a signiﬁcantly reduced
risk of ILI among participants over 65. This is not due the higher vac-
cine uptake in seniors, since vaccine status is already included as a
separate covariate in this multivariate analysis. Seniors are gener-
ally considered a risk group for inﬂuenza, not because of a higher
probability for infection, but due to their greater risk for compli-
cations (Monto, 2004). Having a chronic disease, such as asthma,
diabetes, heart disease or an immune-compromising condition,
was a strong predictor of ILI in the Inﬂuenzanet cohort. People with
these chronic diseases are generally advised to take an inﬂuenza
vaccine. Increased risk of inﬂuenza has been observed in children
with asthma in clinical cohort studies (Gordon et al., 2009), while
diabetes is known to be strongly associated with complications due
to inﬂuenza infections (Irwin et al., 2001). An increased risk of ILI
was observed among the Inﬂuenzanet participants who smoke, as
has been conﬁrmed by other studies (Arcavi and Benowitz, 2004).
The Inﬂuenzanet system is ﬂexible to the extent that questions
of interest can easily be added or removed, allowing for the esti-
mation of risk factors which are not usually considered. In this
study, we  found a small but signiﬁcant protective effect of walk-
ing or bicycling as a primary means of locomotion in comparison
with travelling by car, while no signiﬁcant risk of travelling by pub-
lic transportation was  observed, nor in participants who live with
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Fig. 5. Number of Inﬂuenzanet participants who completed at least 3 symptoms’ questionnaires in (A) the Netherlands, (B) Belgium, (C) Portugal, and (D) Italy. The participants
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lre  differentiated by the season in which they registered. In Portugal in season 20
atabase structure was introduced, providing a reset of participant ids.
ther adults in comparison with adults who live alone. A small
ncrease in risk was observed in participants who have pets at
ome. Practicing sports for at least one hour per week was asso-
iated with a small but signiﬁcant decrease on the ILI risk.
Not only extra questions could be included in the intake ques-
ionnaire, entire new questionnaires could be added in particular
easons enabling further studies. A stress-related questionnaire
eleased in the Netherlands in season 2004–2005 revealed sig-
iﬁcant trends between stress/personality and ILI self-reporting
Smolderen et al., 2007), and a simple questionnaire related to
ontact behaviour, showed that changes in contact patterns could
xplain changes in disease incidence (Eames et al., 2012b).
In 4 out of 10 seasons Inﬂuenzanet estimated a signiﬁcant reduc-
ion in ILI due to vaccination, whereas in the other seasons no
igniﬁcant effect was observed. The direct effectiveness of vacci-
ation varied between 33% (22–42%) in season 2010–2011 and
10% (−28 to 6%) in season 2004–2005. A relatively low vac-
ine effectiveness against ILI is to be expected, since vaccination
argets speciﬁcally the inﬂuenza virus, and not other inﬂuenza-
ike illnesses. A double-blind, randomized, placebo-controlled trial07, in Italy in season 2010–2011, and in all countries in season 2011–2012 a new
measured within the same cohort a vaccine efﬁcacy for serologi-
cally conﬁrmed inﬂuenza of respectively 50% (1997/98) and 86%
(1998/99), but a vaccine effectiveness for ILI of −10% (1997–1998)
and 33% (1998–1999) (Bridges et al., 2000). According to a large
meta-study based on 48 reports on vaccine effectiveness in healthy
adults, inactivated parenteral vaccines were 30% effective against
ILI, and 80% efﬁcacious against inﬂuenza when the vaccine matched
the circulating strain and circulation was  high, but this decreased
to an effectiveness against ILI of 12% and efﬁcacy against inﬂuenza
of 50% when it did not (Demicheli et al., 2009).
For two  seasons (2003–2004 and 2004–2005) Inﬂuenzanet esti-
mated a negative although non-signiﬁcant vaccine effectiveness.
Both seasons were characterized by a poor vaccine match (Belongia
et al., 2009; Jin et al., 2005). A negative vaccine effect can be due
to original antigenic sin, the tendency for antibodies produced in
response to exposure to inﬂuenza vaccine antigens to suppress
the maturation of antibodies with high afﬁnity to the actual virus
(Gupta et al., 2006).
In an observational study of vaccine effectiveness, any preexis-
ting bias between vaccinated and unvaccinated participants could
S.P. van Noort et al. / Epidem
Table  2
Adjusted risk factors and vaccine effectiveness for ILI in the Netherlands, Belgium,
Portugal, and Italy (2003–2013).
Question Answer RR (adjusted)
Age <18 1.59 (1.46–1.74)
18–49 *
50–64 0.82 (0.78–0.86)
65+ 0.46 (0.41–0.51)
Household Alone *
Only with adults 0.99 (0.92–1.05)
With children 1.31 (1.22–1.40)
Gender Male *
Female 1.22 (1.17–1.28)
Chronic
diseases
Asthma or lung disease 1.58 (1.47–1.69)
Diabetes 1.27 (1.15–1.41)
Heart disease 1.29 (1.13–1.47)
Kidney disorder 1.23 (0.80–1.90)
Immune-compromised 1.23 (1.02–1.49)
Risk  group (other)a 1.23 (1.06–1.41)
Smoking 1.16 (1.10–1.22)
Pets Dogs 1.15 (1.09–1.22)
Cats 1.07 (1.02–1.12)
Birds 1.03 (0.94–1.13)
Sports >1 h per week 0.95 (0.90–1.00)
Primary means of
locomotion
Bicycle/foot 0.95 (0.90–1.00)
Car  *
Public transport 0.97 (0.89–1.05)
Vaccination 2003/04 1.07 (0.78–1.47)
2004/05 1.10 (0.94–1.28)
2005/06 0.97 (0.83–1.12)
2006/07 1.00 (0.86–1.15)
2007/08 0.81 (0.70–0.94)
2008/09 0.80 (0.71–0.90)
2009/10b 0.87 (0.74–1.03)
2010/11 0.67 (0.58–0.78)
2011/12 0.97 (0.82–1.16)
2012/13 0.80 (0.71–0.91)
Dependent variable: having at least one ILI episode during a season (inﬂuenza
period).
a Classiﬁed by GP as belonging to risk group due to factors not speciﬁed on this
t
d
i
t
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m
v
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t
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d
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s
a
i
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eable.
b Vaccination for the new H1N1pdm strain.
istort the results. A univariate analysis (Supplementary Table S2)
ndicates a 10% higher ILI reduction in vaccinated participants than
he multivariate study. However, with participants over 65 years of
ge having a lower ILI rate and a relatively high vaccination rate, the
ultivariate model estimates that a part of the reduction in ILI in
accinated participants is due to their age. Although the multivari-
te logistic regression aims to correct for these biases, it is possible
hat other biases not represented by any of the risk factors listed in
able 2 exist.
A cohort study of 72,527 seniors over 65 years of age followed
uring an 8 year period, found that vaccinated seniors already had a
educed risk of death and pneumonia hospitalization in the periods
efore the inﬂuenza season, and that the risk reduction actually
ecreased during the inﬂuenza season (Jackson et al., 2006). Such
 preferential receipt of vaccine by relatively healthy seniors could
ead to overestimation of the vaccine effectiveness in observational
tudies. It is plausible that most elderly Inﬂuenzanet participants
re relatively healthy and that this selection bias is less present
n Inﬂuenzanet, leading to relatively lower estimates of vaccine
ffectiveness than in the average literature. Because of global rec-
mmendations for inﬂuenza vaccination, placebo-controlled trials,
hich could clarify the effects of inﬂuenza vaccines in individuals,
re no longer considered possible on ethical grounds (Jefferson
t al., 2010).ics 13 (2015) 28–36 35
Since the Inﬂuenzanet participants are not a random sample
of the overall population, care should be taken in extrapolating
the estimated risks to the overall population in the respective
countries. However, the observed consistency in risk factors for ILI
between Inﬂuenzanet and those reported by studies in community
settings further establishes that the Inﬂuenzanet population is a
valuable sentinel for ILI surveillance in the population, in addition
to the merits of engaging the participants in public health research
and promoting risk awareness.
The system presented here stands on a concept for syndromic
surveillance that depends on intense activity in science com-
munication, public awareness and sufﬁcient levels of Internet
penetration. It has reported ILI activity in a consistent way for
over 10 seasons in multiple countries. Inﬂuenzanet reports ILI
trends consistent with GP sentinel surveillance (ECDC), and can
complement these systems by providing valuable information
about medical care seeking behaviour. Based on reported symp-
toms, Inﬂuenzanet can be extended to detect diseases other than
inﬂuenza, including those in developing settings. Inﬂuenzanet as an
Internet monitoring system based on voluntary participants might
therefore develop into an important weapon to ﬁght inﬂuenza as
well as other contagious diseases globally.
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